intestinal adenocarcinoma and the influence of metastasis on long‐term survival in 18 cats (2000–2007). Can Vet J 52:1101–1105.249 Greene, S.N. and R.M. Bright. 2008. Insulinoma in a cat. J Small Anim Pract 49:38–40.
250 Greene, S.N., M.D. Lucroy, C.B. Greenberg, et al. 2007. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 231:1056–1060.
251 Greenlee, P.G., D.A. Filippa, F.W. Quimby, et al. 1990. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 66:480–490.
252 Griessmayr, P.C., M. Gauthier, L.G. Barber, et al. 2007. Mushroom‐derived maitake Petfraction as single agent for the treatment of lymphoma in dogs. J Vet Intern Med 21:1409–1412.
253 Griessmayr, P.C., S.E. Payne, J.E. Winter, et al. 2009. Dacarbazine as single‐agent therapy for relapsed lymphoma in dogs. J Vet Intern Med 23:1227–1231.
254 Griffin, A.M., C.I. Dickie, C.N. Catton, et al. 2015. The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma. Ann Surg Oncol 22:2824–2830.
255 Grosenbaugh, D.A., A.T. Leard, P.J. Bergman, et al. 2011. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res 72:1631–1638.
256 Gualtieri, M., M.G. Monzeglio, and M. Di Giancamillo. 1999a. Oesophageal squamous cell carcinoma in two cats. J Small Anim Pract 40:79–83.
257 Gualtieri, M., M.G. Monzeglio, and E. Scanziani. 1999b. Gastric neoplasia. Vet Clin North Am Small Anim Pract 29:415–440.
258 Guerin, V.J., K.W. Thooft, H.F. L’Eplattenier, et al. 2012. Transitional cell carcinoma involving the ductus deferens in a dog. J Am Vet Med Assoc 240:446–449.
259 Guo, Y., C. Shu, X. Zhou, et al. 2012. High‐dose preoperative fractionated radiotherapy does not affect the patency and healing of eptfe vascular prosthesis after replacement of canine abdominal aorta and inferior vena cava. Eur J Vasc Endovasc Surg 43:460–465.
260 Gustafson, N.R., S.E. Lana, M.N. Mayer, et al. 2004. A preliminary assessment of whole‐body radiotherapy interposed within a chemotherapy protocol for canine lymphoma. Vet Comp Oncol 2:125–131.
261 Gyorffy, S., J.C. Rodriguez‐Lecompte, J.P. Woods, et al. 2005. Bone marrow‐derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen. J Vet Intern Med 19:56–63.
262 Hafeman, S., C. London, R. Elmslie, et al. 2010. Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs. Cancer Immunol Immunother 59:441–452.
263 Hafeman, S.D., D. Varland, and S.W. Dow. 2012. Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells. Vet Comp Oncol 10:44–56.
264 Hahn, N.M., P.L. Bonney, D. Dhawan, et al. 2012. Subcutaneous 5‐azacitidine treatment of naturally occurring canine urothelial carcinoma: A novel epigenetic approach to human urothelial carcinoma drug development. J Urol 187:302–309.
265 Hahn, K.A., L. Bravo, W.H. Adams, et al. 1994. Naturally occurring tumors in dogs as comparative models for cancer therapy research. in vivo 8:133–143.
266 Hahn, K.A., G.K. King, and J.K. Carreras. 2004. Efficacy of radiation therapy for incompletely resected grade‐Iii mast cell tumors in dogs: 31 cases (1987–1998). J Am Vet Med Assoc 224:79–82.
267 Hahn, K.A., D.W. Knapp, R.C. Richardson, et al. 1992. Clinical response of nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs. J Am Vet Med Assoc 200:355–357.
268 Hahn, K.A., A.M. Legendre, N.G. Shaw, et al. 2010. Evaluation of 12‐ and 24‐month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Am J Vet Res 71:1354–1361.
269 Hahn, K.A., G. Ogilvie, T. Rusk, et al. 2008. Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med 22:1301–1309.
270 Hajduch, M., Z. Kolar, R. Novotny, et al. 1997. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin‐dependent kinase inhibitor olomoucine. Anticancer Drugs 8:1007–1013.
271 Halle, M., I. Bodin, P. Tornvall, et al. 2009. Timing of radiotherapy in head and neck free flap reconstruction – A study of postoperative complications. J Plast Reconstr Aesthet Surg 62:889–895.
272 Hammer, A.S., C.G. Couto, R.D. Ayl, et al. 1994. Treatment of tumor‐bearing dogs with actinomycin D. J Vet Intern Med 8:236–239.
273 Hammer, A.S., C.G. Couto, J. Filppi, et al. 1991. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5:160–166.
274 Hammer, A., D. Getzy, G. Ogilvie, et al. 2001. Salivary gland neoplasia in the dog and cat: Survival times and prognostic factors. J Am Anim Hosp Assoc 37:478–482.
275 Hanna, F. 2005. Multiple myelomas in cats. J Feline Med Surg 7:275–287.
276 Hansen, K.S., C. Weisse, A.C. Berent, et al. 2012. Use of a self‐expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. J Am Vet Med Assoc 240:1202–1207.
277 Hardie, E.M., J.A. Barsanti, and C. Rawlings. 1984. Complications of prostatic surgery. J Am Anim Hosp Assoc 20:50–56.
278 Hargis, A.M., P.J. Ihrke, W.L. Spangler, et al. 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29:316–328.
279 Harvey, H.J., E.G. Macewen, D. Braun, et al. 1981. Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc 178:580–582.
280 Hasinoff, B.B. 2006. Dexrazoxane use in the prevention of anthracycline extravasation injury. Future Oncol 2:15–20.
281 Havlicek, M., R.S. Straw, V. Langova, et al. 2009. Intra‐operative cisplatin for the treatment of canine extremity soft tissue sarcomas. Vet Comp Oncol 7:122–129.
282 Hayashi, A., H. Tanaka, T. Tajima, et al. 2013. A spayed female cat with squamous cell carcinoma in the uterine remnant. J Vet Med Sci 75:391–393.
283 Heidner, G.L., R.L. Page, M.C. McEntee, et al. 1991. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intraarterial cisplatin. J Vet Intern Med 5:313–316.
284 Heller, D.A., M.E. Stebbins, T.L. Reynolds, et al. 2005. A retrospective study of 87 cases of canine soft tissue sarcomas, 1986–2001. Int J Appl Res Vet Med 3:81–87.
285 Henry, C.J., D.L. Mccaw, S.E. Turnquist, et al. 2003. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 9:906–911.
286 Hermo, G.A., P. Torres, G.V. Ripoll, et al. 2008. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study. Vet J 178:103–108.
287 Hermo, G.A., E. Turic, D. Angelico, et al. 2011. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. J Am Anim Hosp Assoc 47:21–27.
